吉西他滨诱导的血栓性微血管病伴肾病综合征。
Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome.
作者信息
Katagiri Daisuke, Hinoshita Fumihiko
机构信息
Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Nephrology, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, 162-8655, Tokyo, Japan.
出版信息
CEN Case Rep. 2018 Nov;7(2):217-220. doi: 10.1007/s13730-018-0332-3. Epub 2018 May 15.
Abstract
We encountered a case of gemcitabine (GEM)-induced secondary thrombotic microangiopathy (TMA) with nephrotic syndrome. Advanced pancreatic cancer with liver metastasis had originally been diagnosed. Renal biopsy showed focal reduplication of the glomerular basement membrane, endothelial cell swelling, and narrowed capillary lumens with fragmented erythrocytes and fibrin deposition, compatible with TMA. Regular monitoring of renal function during GEM treatment and discontinuation of treatment if acute kidney injury (AKI) might occur is crucial, because AKI combined with TMA is life-threatening.
摘要
我们遇到了一例吉西他滨（GEM）诱发的继发性血栓性微血管病（TMA）合并肾病综合征的病例。最初诊断为晚期胰腺癌伴肝转移。肾活检显示肾小球基底膜局灶性重复、内皮细胞肿胀、毛细血管腔狭窄，伴有破碎红细胞和纤维蛋白沉积，符合TMA表现。在GEM治疗期间定期监测肾功能，若可能发生急性肾损伤（AKI）则停止治疗至关重要，因为AKI合并TMA会危及生命。
相似文献
1
Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome.
CEN Case Rep. 2018 Nov;7(2):217-220. doi: 10.1007/s13730-018-0332-3. Epub 2018 May 15.
2
Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report.
BMC Nephrol. 2021 May 12;22(1):175. doi: 10.1186/s12882-021-02386-y.
3
The Detection of Urinary Podocytes from Drug-Induced Glomerular Thrombotic Microangiopathy in Advanced Cancer Patients.
Clin Lab. 2016 Dec 1;62(12):2413-2417. doi: 10.7754/Clin.Lab.2016.160525.
4
Decitabine-induced kidney thrombotic microangiopathy with glomerular crescents formation and tubular necrosis: A case report.
Medicine (Baltimore). 2020 Oct 23;99(43):e22901. doi: 10.1097/MD.0000000000022901.
5
Gemcitabine-induced thrombotic microangiopathy.
Intern Med J. 2013 Nov;43(11):1240-2. doi: 10.1111/imj.12261.
6
The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
BMC Nephrol. 2018 Jan 12;19(1):9. doi: 10.1186/s12882-018-0812-x.
7
Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series.
J Chemother. 2014 Jun;26(3):169-72. doi: 10.1179/1973947813Y.0000000122. Epub 2013 Dec 6.
8
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre.
BMC Nephrol. 2021 Jul 21;22(1):267. doi: 10.1186/s12882-021-02470-3.
9
Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes.
J Cutan Pathol. 2012 Jul;39(7):707-11. doi: 10.1111/j.1600-0560.2012.01918.x. Epub 2012 May 22.
10
Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.
Br J Clin Pharmacol. 2019 Feb;85(2):403-412. doi: 10.1111/bcp.13808. Epub 2018 Dec 18.
引用本文的文献
1
Melatonin augments anti-tumor activity and alleviates nephrotoxicity of gemcitabine in a pancreatic cancer xenograft model targeting P62/Keap1 pathway.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 18. doi: 10.1007/s00210-025-03938-x.
2
Nephrotic Syndrome and Posterior Reversible Encephalopathy Syndrome as Clinical Presentations of Gemcitabine-Induced Thrombotic Micro-Angiopathy.
Indian J Nephrol. 2024 Jan-Feb;34(1):74-78. doi: 10.4103/ijn.ijn_277_22. Epub 2023 Mar 7.
3
Gemcitabine-Induced Renal Thrombotic Microangiopathy.
Indian J Nephrol. 2023 Jul-Aug;33(4):319-320. doi: 10.4103/ijn.ijn_321_22. Epub 2023 Mar 8.
4
Time to Onset of Gemcitabine-induced Thrombotic Microangiopathy in a Japanese Population: A Case Series and Large-scale Pharmacovigilance Analysis.
Cancer Diagn Progn. 2023 Jan 3;3(1):115-123. doi: 10.21873/cdp.10188. eCollection 2023 Jan-Feb.
5
Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma.
Case Rep Nephrol. 2022 Sep 28;2022:8677293. doi: 10.1155/2022/8677293. eCollection 2022.
6
A rare case report of gemcitabine-induced thrombotic microangiopathies.
SAGE Open Med Case Rep. 2021 May 24;9:2050313X211013208. doi: 10.1177/2050313X211013208. eCollection 2021.
7
A Case of Gemcitabine-Induced Thrombotic Microangiopathy Treated With Ravulizumab in a Patient With Stage IV Pancreatic Cancer.
Cureus. 2021 Jan 31;13(1):e13031. doi: 10.7759/cureus.13031.
8
COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.
J Am Soc Nephrol. 2020 Sep;31(9):1948-1958. doi: 10.1681/ASN.2020050699. Epub 2020 Jul 13.
本文引用的文献
1
Thrombotic Microangiopathy and the Kidney.
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):300-317. doi: 10.2215/CJN.00620117. Epub 2017 Oct 17.
2
HUS and atypical HUS.
Blood. 2017 May 25;129(21):2847-2856. doi: 10.1182/blood-2016-11-709865. Epub 2017 Apr 17.
3
The Detection of Urinary Podocytes from Drug-Induced Glomerular Thrombotic Microangiopathy in Advanced Cancer Patients.
Clin Lab. 2016 Dec 1;62(12):2413-2417. doi: 10.7754/Clin.Lab.2016.160525.
4
Clinical guides for atypical hemolytic uremic syndrome in Japan.
Clin Exp Nephrol. 2016 Aug;20(4):536-543. doi: 10.1007/s10157-016-1276-6.
5
Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.
Kidney Int. 2016 Feb;89(2):374-85. doi: 10.1038/ki.2015.327.
6
Gemcitabine-induced hemolytic uremic syndrome mimicking scleroderma renal crisis presenting with Raynaud's phenomenon, positive antinuclear antibodies and hypertensive emergency.
Intern Med. 2014;53(5):445-8. doi: 10.2169/internalmedicine.53.1160.
7
Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
Gut Liver. 2014 Jan;8(1):109-12. doi: 10.5009/gnl.2014.8.1.109. Epub 2014 Jan 13.
8
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.
Br J Haematol. 2014 Mar;164(6):759-66. doi: 10.1111/bjh.12718. Epub 2014 Jan 6.
9
Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Br J Haematol. 2013 Nov;163(4):514-9. doi: 10.1111/bjh.12569. Epub 2013 Sep 20.
10
Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection.
J Am Soc Nephrol. 2013 Dec;24(12):2034-43. doi: 10.1681/ASN.2013020134. Epub 2013 Oct 3.
Zotero 插件